Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Mercury Biopharmaceutical Corporation (6932.TWO)

Compare
12.85
-0.05
(-0.39%)
As of 11:07:17 AM GMT+8. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Yaoren Liang GM & Director -- -- --
Chun Chun Zhang Accounting Supervisor -- -- --

Mercury Biopharmaceutical Corporation

15th Floor
No. 653, Bannan Road Zhonghe District
New Taipei City
Taiwan
886 2 8221 2020 https://merdury.com
Sector: 
Healthcare

Description

Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.

Corporate Governance

Mercury Biopharmaceutical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

6467.TWO TAHO Pharma
58.90
0.00%
 
6677.TWO Anxo Pharmaceutical Co., Ltd.
18.90
+4.13%
 
4166.TWO Orient Pharma Co., Ltd.
30.30
+0.66%
 
4172.TWO InnoPharmax Inc.
14.65
-1.68%
 
6620.TWO Handa Pharmaceuticals, Inc.
70.70
+2.02%
 
6539.TWO DV Biomed Co., Ltd.
62.00
-0.16%
 
6621.TWO UniPharma Co., Ltd.
15.90
+5.30%
 
4117.TWO General Biologicals Corporation
13.75
0.00%
 
4132.TWO Golden Biotechnology Corporation
13.05
0.00%
 
4747.TWO Johnson Chemical Pharmaceutical Works Co., Ltd.
67.00
+3.24%